Archer-Daniels-Midland (ADM) reported its fourth-quarter earnings for fiscal year 2024, revealing an adjusted earnings per share (EPS) of $1.14, matching analyst expectations. However, the company's revenue of $21.5 billion fell short of the anticipated $22.68 billion. In light of these results, ADM announced a quarterly dividend increase and a cost-saving plan projected to save between $500 million and $750 million. The company also provided guidance for adjusted EPS in fiscal year 2025, forecasting a range between $4.00 and $4.75, slightly below the consensus estimate of $4.66. Meanwhile, Fair Isaac Corporation (FICO) reported a first-quarter fiscal 2025 adjusted EPS of $6.14, exceeding expectations, with a net income of $152.5 million and a cash flow of $194 million. FICO's revenue for the quarter was $440 million, slightly below the forecasted figures. The company anticipates full-year EPS of $28.58, compared to the estimate of $29.42. Additionally, Boston Scientific (BSX) reported a fourth-quarter adjusted EPS of $0.70, surpassing the estimate of $0.66, with revenues of $4.56 billion, also above expectations. The company projects adjusted EPS for fiscal year 2025 in the range of $2.80 to $2.87. CDW Corporation's fourth-quarter results showed an adjusted EPS of $2.48 and revenues of $5.19 billion, both exceeding analyst estimates. CDW's strong performance was driven by significant growth in its healthcare segment.